Conference Coverage

How to prevent 1 million coronary events

Publish date: January 18, 2013

 

AT THE ANNUAL SCIENTIFIC SESSIONS OF THE AMERICAN HEART ASSOCIATION

This analysis was funded by Bristol-Myers Squibb. Dr. Wong reported receiving a research grant from that company to conduct the study. In addition, he serves as a consultant to Merck, LipoScience, and Reengineering Healthcare.

b.jancin@elsevier.com

Pages

Recommended Reading

Practice Changer: CABG Bests Multivessel Stenting in Diabetes
MDedge Cardiology
Aliskiren Didn't Protect Heart, Kidneys in Diabetes
MDedge Cardiology
Insulin Degludec's Long Duration Sways FDA Panel
MDedge Cardiology
Statins Sever the Diabetes and Coronary Disease Link
MDedge Cardiology
In Type 1 Diabetes, Cardiac Measures Improved After Pancreas Transplant
MDedge Cardiology
DPP-4 Inhibitors for Diabetes May Cut Cardiovascular Risk
MDedge Cardiology
Statins' Diabetogenic Impact Influenced by Underlying Risks
MDedge Cardiology
Bariatric surgery cut vascular events in diabetes
MDedge Cardiology
FDA panel backs approval of canagliflozin for type 2 diabetes
MDedge Cardiology
SSRIs for PTSD bring cardiometabolic benefits
MDedge Cardiology